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DObjective: Commonly used procedures to repair functional tricuspid regurgitation have a high failure rate. The
present study was designed to lower this failure rate by reducing leaflet tethering via pericardial patch augmen-
tation when the preoperative probability of recurrence was high.
Methods: Between 2001 and 2007, 210 patients with severe functional tricuspid regurgitation underwent tricus-
pid valve repair at the Day General Hospital. With respect to the type of repair, the patients were randomly divided
into 4 groups: (1) De Vega in 52 patients; (2) ring annuloplasty in 53 patients; (3) De Vega and, if indicated by the
preoperative tethering index (tethering distance>8 mm or tethering area>16 mm2), pericardial patch augmen-
tation in 53 patients; and (4) ring annuloplasty and, if indicated by the preoperative tethering index (tethering
distance> 8 mm or tethering area> 16 mm2), pericardial patch augmentation in 52 patients. The results of
1-month and 1-year postoperative tricuspid regurgitation were evaluated.
Results: Fifteen patients in group 3 and 15 patients in group 4 met the criterion for the complementary procedure.
Postoperative tricuspid regurgitation was different between the groups (P<.05): 16.0% and 28.0% of patients in
the De Vega group, 8.0% and 14.0% of patients in the ring annuloplasty group, 4.0% and 10.0% of patients in
the De Vegaþpericardial patch augmentation group, and 2.0% and 8.0% of patients in the ring annuloplastyþ
pericardial patch augmentation group had postoperative tricuspid regurgitation at 1-month and 1-year follow-up,
respectively.
Conclusion: An assessment of preoperative tricuspid valve tethering to select patients suitable for augmentation
contributes to a good surgical outcome in patients with severe functional tricuspid regurgitation. (J Thorac
Cardiovasc Surg 2010;139:1483-7)Functional tricuspid regurgitation (TR) appears in conjunc-
tion with left-sided valve disease and left ventricular dys-
function despite the presence of a structurally normal
tricuspid valve (TV). Surgical repair of functional TR during
the operation of left-sided heart disease is recommended be-
cause the persistence of significant TR begets a significant
increase in postoperative morbidity and mortality.1-3 Func-
tional TR is thought to be caused by the dilatation of the
TV annulus and tethering of the tricuspid leaflet, subsequent
to right ventricular (RV) dilatation.4-6 TR severity is related
to both dilated TV annulus and leaflet tethering, which de-
crease the degree of leaflet overlap or coaptation at the
tips.6 If performed to reduce the TV annulus, however, these
modalities might not be sufficient to correct functional TR,
with more than mild residual TR occurring in up to 20%
of patients early after annuloplasty and in more than 40%
of patients after De Vega.7-10 Unfortunately, the mechanisme Day General Hospital, Tehran, Iran.
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The Journal of Thoracic and Carand determinants of residual TR after TV repair have not
been fully investigated and thus remain unknown.
In light of a previous study demonstrating that the severity
of preoperative TV leaflet tethering distance and area could
predict significant residual TR after TV annuloplasty,10 we
sought to reduce the failure rate of TR repair by lessening
leaflet tethering via pericardial patch augmentation when
the preoperative probability of recurrence was high.MATERIALS AND METHODS
Study Population
The present study included 293 consecutive patients, selected for func-
tional TR repair at Day General Hospital. Patients with pacemaker wires
across the TV, congenital heart disease, and inadequate visualization
on echocardiography were excluded. The final population of this study
was composed of 210 patients (74 men and 136 women at a mean age of
55.2  10.0 years). The study protocol was approved by the institutional
Ethics Committee on Human Studies at Day General Hospital.
Patients were examined using 2-dimensional transthoracic echocardiog-
raphy (TTE) before and after cardiac surgery. Postoperative echocardiogra-
phy was performed at a follow-up of 1 month and 1 year after cardiac
surgery.
The main left-sided lesions were mitral valve in 143 patients, aortic valve
in 1 patient, both mitral and aortic valves in 43 patients, and combined valve
and coronary artery disease in 23 patients.
Eighty-seven patients (47.1%) had previous cardiac surgery: 55 for the
mitral valve, 8 for the aortic valve, 12 for both mitral and aortic valves, and
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Thright ventricularTEE ¼ transesophageal echocardiography
TR ¼ tricuspid regurgitation
TTE ¼ transthoracic echocardiography
TV ¼ tricuspid valvebeen carried in 28 patients. A total of 151 patients (71.9%) had atrial fibril-
lation.
Patients were randomly divided into 4 groups by type of repair: (1) De
Vega in 52 patients; (2) ring annuloplasty in 53 patients; (3) De Vega
and, and if indicated by the preoperative tethering index (tethering
distance>8 mm or tethering area>16 mm2), pericardial patch augmenta-
tion in 53 patients; and (4) ring annuloplasty and, if indicated by the preop-
erative tethering index (tethering distance> 8 mm or tethering area> 16
mm2), pericardial patch augmentation in 52 patients.
Echocardiographic Measurements
In this prospective study, all the echocardiograms were obtained by 2
blinded cardiologists. Two-dimensional TTE was performed as routine
before and after cardiac surgery with Vivid 7 (GE Medical Systems,
Waukesha, WI). In the 4-chamber view, RV end-systolic and end-diastolic
areas were measured via planimetry and tracing the endocardial outline of
the RV and the plane of the TV. RV fractional area change was calculated
as end-diastolic area minus end-systolic area divided by end-diastolic
area3 100.11,12 TV annulus diameter wasmeasured in the apical 4-chamber
view as the distance between the points of reflection of the septal and mural
endocardium on the anterior and septal tricuspid leaflets, respectively. The
TV coaptation depth and tethering area were measured by tracing between
the atrial surface of the leaflets and the tricuspid annular plane at the time
of maximal systolic closure (Figure 1). TR severity was assessed via color
Doppler flowmapping of the spatial distribution of the regurgitant jet within
the right atrium. TR jet area on the color flow mapping (Figure 2) and the
right atrium in the same frame were measured by planimetry, and the ratio
of the maximal regurgitant area to right atrium area (%TR) was thereafter
obtained. In accordance with previous studies,6,13,14 residual TR after TV
annuloplasty was graded as mild if it occupied less than 20%, moderate if
it was between 20% and 34%, and severe if it was greater than 34% on fol-
low-up echocardiography. Left ventricular ejection fraction was also
obtained by using Simpson’s rule methods from apical 4- and 2-chamber
views.After TV systolic velocitywas recordedwith continuous-waveDopp-
ler, RV systolic pressure was calculated by Modified Bernoulli gradient þ
estimated right atrium pressure based on the inferior vena cava pattern.
It should be noted that transesophageal echocardiography (TEE) was
done in all the patients. However, because TR can vary significantly and
be underestimated during surgery and after anesthesia, we chose TTE
over TEE so that the patients would be under a normal and stable condition.e TV coaptation depth (A) and tethering area (B) were measured
of maximal systolic closure.
e Journal of Thoracic and Cardiovascular SurSurgical Procedure
The operations were performed through a median sternotomy with extra-
corporeal circulation. TV repair was carried out subsequent to the surgical
correction of the mitral or aortic valve. Myocardial protection was achieved
with antegrade or retrograde cardioplegia.
Patients with aortic lesions (n ¼ 48) underwent aortic prosthetic valve
replacement (mechanical prostheses in 38 patients and bioprostheses in
10 patients). Patients with mitral lesions (n ¼ 185) underwent mitral pros-
thetic valve replacement (n ¼ 120; mechanical prostheses, 82 and biopros-
theses, 38) or mitral valve repair (n ¼ 65; flexible ring annuloplasty, 57;
mitral commissurotomy, 20; thinning of the subvalvular apparatus, 12;
and leaflet augmentation, 13).
An autologous piece of pericardium was harvested immediately after
median sternotomy and immersed in 3% glutaraldehyde for 15 minutes.
The patients were placed on standard cardiopulmonary bypass with bicaval
cannulation, and standard blood cardioplegic arrest was initiated with ante-
grade and retrograde cardioplegia. In cases of an enlarged left atrium, the
mitral valve was replaced via a left atriotomy, which was followed by a right
atriotomy to repair the tricuspid valve. On the other hand, when the left
atrium was small, the mitral valve was replaced through the interatrial
groove via right atriotomy and subsequently the tricuspid valve was re-
paired. Annuloplasty sutures with 2-0 Ethibond were used to bring the valve
closer to the surgical field. A curvilinear incision was thereafter made in the
anterior leaflet parallel to the anterior annulus, from commissure to commis-
sure, leaving 1 to 2 mm of leaflet tissue. The secondary order chordae of the
leaflet were cut to confer mobilization.
The autologous patch was then generously fashioned to a suitable size;
great care was exercised to ensure that the length of the patch was at least
the same as the commissure to commissure distance and that the width of
the patch was 8 to 12 mm (depending on which part of the leaflet was
more shortened) in an effort to restore the coaptation zone between the leaf-
lets and avert leaflet prolapse. Once appropriately sized, the patch was sewn
into the defect of the anterior leaflet with 2 running 5-0 Prolene sutures. A
complete ring annuloplasty procedure or De Vega was subsequently per-
formed in the patients. For annular ring procedure, the Carpentier-Edwards
ring (Baxter Healthcare Corp, Santa Ana, Calif) was used. The length of the
base of the septal leaflet (intertrigonal distance) determined the size of the
ring. All the rings were downsized by 2 sizes.
De Vega repair was performed by a partial purse-string reduction of the
anterior and posterior leaflet annulus. The judgment regarding the degree of
annular reduction was based on the degree of annular reduction using the
ring annuloplasty sizers designed for the tricuspid valve (with the rule of
undersizing the ring by 2 sizes).
The completed repair restored the intraventricular zone of coaptation,
which was confirmed at the time of repair by filling the RV with saline
through a bulb syringe and visually inspecting the leaflets in conjunction
with intraoperative TEE.
Statistical Analysis
All the results are expressed as mean standard deviation. The nominal
and continuous variables were compared using the chi-square test and anal-
ysis of variance, respectively. A post hoc comparison was made via theby tracing between the atrial surface of the leaflets and the tricuspid annular
gery c June 2010
FIGURE 2. Comparison of preoperative and postoperative TR among the




Roshanali et al Acquired Cardiovascular DiseaseBonferroni test. In addition, a general linear model was used to compare the
repeated measurements of the differences in postoperative TR in the 4
groups.
RESULTS
There were 10 (4.8%) hospital mortalities, the causes of
death being heart failure in 6, respiratory insufficiency in 2,
andmultiorgan failure in 2.With regard to the 4 groups of pa-
tients, hospital mortality occurred in 3.8% of the De Vega
group (2/52), 5.7% of the ring annuloplasty group (3/53),
5.7% of the De Vega þ pericardial patch augmentation
group (3/53), and 3.8% of the ring annuloplasty þ peri-
cardial patch augmentation group (2/52). Fifty patients
survived in each group. The difference in the mortality
rates among the 4 groups was not statistically significant
(P> .05).
There was no difference among the 4 groups in male-
to-female ratio, age, ejection fraction, New York Heart
Association Class, mitral valve surgery, and aortic valve
surgery (P> .05) (Table 1), and there was no statistically
significant difference in RV systolic pressure, annulus, RV
fractional area, right atrial area, and preoperative TR
(P> .05) (Table 1).TABLE 1. Comparison of the characteristics in the 4 groups before surger
Variable De Vega Annuloplasty
Sex (M/F) 20/32 18/35
Age (mean  SD) 55.0  0.5 55.9  10.3
LVEF (%) (mean  SD) 40.4  7.5 44.0  9.5
RVFA (%) (mean  SD) 29.8  4.8 28.2  5.1
RA-A (cm2) (mean  SD) 31.2  8.3 32.9  8.2
RVSP (mm Hg) (mean  SD) 54.4  8.9 53.9  9.1
Annulus (cm) (mean  SD) 36.4  4.5 36.3  4.0
TET-A (cm2) (mean  SD) 15.3  6.1 13.6  5.5
TET-D (cm) (mean  SD) 6.3  2.4 5.9  2.1
Preoperative TR (%) (mean  SD) 2.88  0.32 2.85  0.36
NYHA (mean  SD) 2.9  0.8 2.8  0.8
MV surgery (%) 85.5 88.7
AV surgery (%) 23.6 20.8
LVEF, Left ventricular ejection fraction; RVFA, right ventricular fractional area change; RA
TET-D, tethering distance; TR, tricuspid regurgitation; SD, standard deviation; NYHA, New
The Journal of Thoracic and CarAt 1-year follow-up, mitral valve repair failure developed
in 3 patients: 1 in the De Vega group, 1 in the De Vega þ
pericardial patch augmentation group, and 1 in the ring an-
nuloplasty þ pericardial patch augmentation group. Only
the latter had severe TR at 1-year follow-up. We found no
correlation between mitral valve repair failure and TR recur-
rence.
Severe postoperative TR was different among the
groups at follow-up. It should be noted, however, that
this difference in TR between the groups with and without
the patch was not large (Figure 3): 16.0% and 28.0%
patients in the De Vega group, 8.0% and 14.0% in the
ring annuloplasty group, 4.0% and 10.0% in the De
Vega þ pericardial patch augmentation group, and 2.0%
and 8.0% in the ring annuloplasty þ pericardial patch
augmentation group had postoperative TR at 1-month and
1-year follow-up, respectively. There was a significant dif-
ference between groups 1 and 4 (P< .05). The mean TR
was 1.6  0.753 in the De Vega group, 1.38  0.63 in
the annuloplasty group, 1.42  0.575 in the De Vega þ
pericardial patch augmentation group, and 1.18  0.438
in the annuloplastyþpericardial patch augmentation group.
DISCUSSION
TV regurgitation with the concomitant disease of the mi-
tral or aortic valve, or both, has been consistently associated
with a high mortality rate and an increased risk of early- and
late-phase adverse events.15,16
Previous studies have demonstrated that despite continu-
ing advances in the diagnosis and management of valvular
heart disease, TV surgery remains challenging.17-19 Most se-
ries have reported the operative mortality for TV replace-
ment to be between 14.3% and 24.5%,15,20-24 and as
a result TV repair has remained the preferred choice for pa-
tients with TR. TV repair can become even more compli-
cated if there is an associated abnormality of the valve and
subvalvular apparatus. Annuloplasty sometimes does noty
De Vegaþpericardial Ringþpericardial P value
21/32 18/34 .932
56.0  10.0 54.7  10.0 .879
43.8  9.1 42.5  8.9 .117
28.3  5.3 28.7  5.0 .299
31.2  8.4 33.8  8.6 .275
53.6  9.0 52.2  8.6 .624
36.9  3.9 37.9  5.6 .292
15.0  5.9 15.4  6.7 .418
6.8  2.4 6.7  2.3 .132
2.75  0.43 2.85  0.36 .325
2.9  0.8 2.7  0.9 .667
89.3 88.9 .921
23.2 22.2 .985
-A, right atrial area; RVSP, right ventricular systolic pressure; TET-A, tethering area;
York Heart Association; MV, mitral valve; AV, aortic valve.
diovascular Surgery c Volume 139, Number 6 1485




Acquired Cardiovascular Disease Roshanali et alcompletely resolve this problem, and severe residual TR
may persist. Therefore, averting severe residual TR is a great
challenge that many cardiac surgeons face.
Residual TR of more than grade 2 early after tricuspid an-
nuloplasty is believed to be a significant risk factor for late
TV reoperation.25 In Fukuda and colleagues’ study,10 resid-
ual TR was rated as severe in 7.4% and moderate in 15% of
216 patients. The incidences of severe residual TR were
6.7% and 14% in patients with ring and non-ring annulo-
plasty, respectively.10
McCarthy and colleagues7 reported that the prevalence of
3þor 4þ residual TR was 14% in 790 patients. Onoda and
colleagues8 measured postoperative TR after Carpentier
ring annuloplasty and observed moderate TR in 29% of
31 patients. Rivera and colleagues9 reported that significant
residual TR, assessed through clinical findings or right ven-
triculography, was observed in 22% of 81 patients. They
also found the incidence of significant TR to be lower in
patients with the Carpentier ring (10%) than in those with
De Vega non-ring (43%) annuloplasty.
In our study, the incidence of severe residual TR was
16.0% in those who underwent De Vega and 8.0% in those1486 The Journal of Thoracic and Cardiovascular Surwho had ring annuloplasty, both without pericardial patch
augmentation.
TV annulus dilatation and leaflet tethering are regarded as
important mechanisms in the development of functional
TR.4-6 Changes in the RV geometry are thought to cause
the displacement of the papillary muscles, resulting in the
tethering of the TV leaflet. The ideal TV annuloplasty or
De Vega would resolve the incomplete TV coaptation insti-
gated by both TV annular dilatation and leaflet tethering, but
sometimes these modalities are not sufficient to correct
a highly tethered TV.10
Attempts were made in the present study to identify TV
tethering, as was described by Fukuda and colleagues,10
and to resolve it via pericardial patch augmentation. Conse-
quently, augmentation was carried out in conjunction with
the procedure in those with a high tethering index (15 of
the 53 patients in the De Vega group and 15 of the 52
patients in the annuloplasty group), which yielded far better
results by comparison with the patients who underwent De
Vega and ring annuloplasty alone. Residual TR decreased
to 4.0% persons in the De Vegaþpericardial patch augmen-
tation group and to 2.0% persons in the ring annuloplastyþ
pericardial patch augmentation group.
Leaflet augmentation can resolve residual TR after repair;
nevertheless, it is time-consuming and not suitable for all pa-
tients, because more often than not there is another valvular
involvement or the procedure is a redo. Furthermore, an in-
creased pump-time can prove pernicious to these already
high-risk patients. It is, therefore, advisable that we deter-
mine before surgery whether the patient has a high probabil-
ity of repair failure so that we can perform augmentation in
conjunction with the routine modality.
In light of Fukuda and colleagues’ study,10 we selected
these patients on the basis of their tethering distance and
tethering area and succeeded in achieving excellent results
with little significant residual TR. This study demonstrates
that relieving TV tethering in patients with severely tethered
valve may significantly reduce the probability of TV repair
failure.
Limitations
This study was based on the evaluation of residual TR in
tricuspid valve augmentation in patients with highly tethered
TV; consequently, the patients should have been followed
up and evaluated for the recurrence of TR. Longer observa-
tion periods are required to validate the effectiveness of this
method of patient selection and durability of this technique.
CONCLUSIONS
To reduce the rate of tricuspid valve repair failure, both
leaflet tethering and annular dilatation should be considered.
Moreover, a thorough assessment of preoperative TV tether-
ing is essential to define the surgical indication of augmen-
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